Waldenstrom's Macroglobulinemia Program Dana-Farber Cancer Institute
  Publications
  Media
 
 
  Email this page to a friend >

 

   
 

Below are all of the recent publications on Waldenstroms macroglobulinemia that our program has assisted in. Those interested in reading one of the full articles should consult a local medical library for back issues of the journal in which the article appeared or purchase a reprint online directly from the journal's web page.

Sort By:  

Show Publications By:


Bortezomib as a Treatment Option in Patients With Waldenstrom Macroglobulinemia
4/6/2010
By M Dimopoulos, C Chen, E Kastritis, M Gavriatopoulou, SP Treon

Phase II Trial of the Oral Mammalian Target of Rapamycin Inhibitor Everolimus in Relapsed or Refractory Waldenström Macroglobulinemia
3/10/2010
By IM Ghobrial, MA Gertz , B LaPlant, J Camoriano, S Hayman, M Lacy, S Chuma, B Harris, R Leduc, M Rourke, S Ansell, D DeAngelo, A Dispenzieri, L Bergsagel, C Reeder, KC Anderson, P Richardson, SP Treon, TE Witzig

Phase II Trial of Weekly Bortezomib in Combination With Rituximab in Relapsed or Relapsed and Refractory Waldenström Macroglobulinemia
3/10/2010
By IM Ghobrial, F Hong, S Padmanabhan, A Badros, M Rourke, R Leduc, S Chuma, J Kunsman, D Warren, B Harris, A Sam, KC Anderson, P Richardson, SP Treon, E Weller, J Matous

IgA and IgG hypogammaglobulinemia in Waldenström’s macroglobulinemia
11/10/2009
By ZR Hunter, R Manning, C Hanzis, B Ciccarelli, L Ioakimidis, C Patterson, M Lewicki, H Tseng, P Gong, X Liu, Y Zhou, G Yang, J Sun, L Xu, P Sheehy, M Morra, SP Treon

How I Treat Waldenstrom's Macroglobulinemia
7/17/2009
By Steven Treon


View All Publications >>